Befotertinib Mesylate
- Generic Name
- Befotertinib Mesylate
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer
- First Posted Date
- 2019-03-04
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- InventisBio Co., Ltd
- Target Recruit Count
- 290
- Registration Number
- NCT03861156
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
D-0316 First Time in Patients Ascending Dose Study
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- InventisBio Co., Ltd
- Target Recruit Count
- 84
- Registration Number
- NCT03452150
- Locations
- 🇨🇳
Research Site, Hangzhou, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath